Day :
- Current Challenges in Developing Biosimilars | Clinical Development of Biosimilars | Biosimilars Analytical Strategies | Biosimilars Companies and Market Analysis | Current Trends in Pharmaceutical Industries | Challenges in Biosimilars Pharmacovigilance
Location: Boston, USA

Chair
Peter H. Kalinka
Longmore 60 Biotech Inc., USA
Session Introduction
Neil Schauer
Schauer Biologics Consulting LLC, USA
Title: Risk based development and manufacturing of biosimilars

Biography:
Abstract:
Louis Boon
Bioceros BV, Poland
Title: Using SPOT™ and SLIM™ technology in our CHOBC® platform to reduce cost of goods of biosimilars

Biography:
Abstract:

Biography:
Abstract:

Biography:
Abstract:
Anita Burrell
Health Strategies Group, USA
Title: Understanding the market access landscape for biosimilars

Biography:
Abstract:
Karlheinz Landauer
Quality Biotech Development & Cells GmbH, Switzerland
Title: How to start a biosimilar development: A risk based approach

Biography:
Abstract:
- Regulatory Approach for Biosimilars | Globalization of Biosimilars | Biosimilars Research Pipeline| Analytical Characterization of Biotherapeutics |Biopharmaceutical Regulatory Affairs
Location: Boston, USA

Chair
Leigh-Ann M. Durant,
EMD Serono, Inc., USA
Session Introduction
Nitin Naik
Frost and Sullivan, USA
Title: Transformations in global pharmaceutical indutsry

Biography:
Abstract:
Gregory Gierer
America’s Health Insurance Plans, USA
Title: Health plan perspective: Assuring a vibrant and competitive marketplace for biosimilars

Biography:
Abstract:
Jose Carlos Ferreyra Lopez
The Pharmaceutical Institute, Mexico
Title: Market access barriers and market value in Mexican public sector for biosimilars

Biography:
Abstract:

Biography:
Abstract:
Sabiruddin Mirza
Harvard University, USA
Title: Microfluidics: An advanced platform for pharmaceutical protein formulation
